MARSH & MCLENNAN COMPANIES, INC. (MRSH)
Data as of , from SEC Form 4 filings.
See up to 3 months of MRSH. The 7-day demo opens the 1M and 3M ranges and puts MRSH on your watchlist.
Start 7-day demoLatest MRSH insider trades
About MARSH & MCLENNAN COMPANIES, INC. (MRSH)
The SEC lists MARSH & MCLENNAN COMPANIES, INC. under CIK 0000062709, in insurance agents, brokers and service. We track it alongside the rest of the Financials sector.
MRSH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 44,166 | $8.21M |
| Grant or award | 5 | 972.9 | |
| Option exercise | 4 | 35,706 | |
| Other acquisition / disposition | 7 | 845.96 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MRSH insider transactions (Form 4)
41120 Form 4 filings on record, the earliest from Oct 31, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Option exercise | Common Stock | 1,197 | $83.05 | $99K | ||
| Open-market sale | Common Stock | 1,197 | $187.90 | $225K | ||
| Option exercise | Stock Options (Right to Buy) | 1,197 | $0.00 | - | ||
| John Q. Doyle - Officer | Option exercise | Common Stock | 16,656 | $73.20 | $1.22M | |
| John Q. Doyle - Officer | Open-market sale | Common Stock | 16,656 | $188.51 | $3.14M | |
| John Q. Doyle - Officer | Option exercise | Stock Options (Right to Buy) | 16,656 | $0.00 | - | |
| Other | Restricted Stk. Units-Dir. Stk. Plan | 473.39 | $189.15 | $90K | ||
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 218.9 | $188.45 | $41K | ||
| Anthony Anderson - Director | Other | Restricted Stk. Units-Dir. Stk. Plan | 89.41 | $189.15 | $17K | |
| Deborah C. Hopkins - Director | Other | Restricted Stk. Units-Dir. Stk. Plan | 112.08 | $189.15 | $21K | |
| Tamara Ingram - Director | Other | Restricted Stk. Units-Dir. Stk. Plan | 47.56 | $189.15 | $9K | |
| Other | Restricted Stk. Units-Dir. Stk. Plan | 64.85 | $189.15 | $12K | ||
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 223.73 | $188.45 | $42K | ||
| Other | Restricted Stk. Units-Dir. Stk. Plan | 46.64 | $189.15 | $9K | ||
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 144.27 | $188.45 | $27K | ||
| Other | Restricted Stk. Units-Dir. Stk. Plan | 12.03 | $189.15 | $2K | ||
| Steven A. Mills - Director | Grant or award | Common Stock | 194 | $188.45 | $37K | |
| Bruce D. Broussard - Director | Grant or award | Common Stock | 192 | $188.45 | $36K | |
| Open-market sale | Common Stock | 6,500 | $191.96 | $1.25M | ||
| Paul Beswick - Officer | Open-market sale | Common Stock | 713 | $198.00 | $141K | |
| Martin South - Officer | Open-market sale | Common Stock | 7,100 | $189.99 | $1.35M | |
| Open-market sale | Common Stock | 12,000 | $175.65 | $2.11M | ||
| John Q. Doyle - Officer | Option exercise | Common Stock | 16,656 | $73.20 | $1.22M | |
| John Q. Doyle - Officer | Open-market sale | Common Stock | 16,656 | $161.71 | $2.69M | |
| John Q. Doyle - Officer | Option exercise | Stock Options (Right to Buy) | 16,656 | $0.00 | - | |
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | ||
| Anthony Anderson - Director | Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | |
| Deborah C. Hopkins - Director | Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | |
| Tamara Ingram - Director | Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | |
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | ||
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | ||
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 1,350 | $159.28 | $215K | ||
| Steven A. Mills - Director | Grant or award | Common Stock | 1,349 | $159.28 | $215K | |
| H. Edward Hanway - Director | Grant or award | Common Stock | 1,349 | $159.28 | $215K | |
| Judith Hartmann - Director | Grant or award | Common Stock | 1,349 | $159.28 | $215K | |
| Peter Harrison - Director | Grant or award | Common Stock | 1,350 | $159.28 | $215K | |
| Peter Harrison - Director | Tax withholding / forfeiture | Common Stock | 103.39 | $159.28 | $16K | |
| Bruce D. Broussard - Director | Grant or award | Common Stock | 1,349 | $159.28 | $215K | |
| Grant or award | Restricted Stk. Units-Dir. Stk. Plan | 256.85 | $160.60 | $41K | ||
| Other | Restricted Stk. Units-Dir. Stk. Plan | 495.08 | $160.60 | $80K | ||
| Deborah C. Hopkins - Director | Other | Restricted Stk. Units-Dir. Stk. Plan | 111.82 | $160.60 | $18K |
Recent MRSH Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Doyle John Q | Officer, Director | 16,656 | $3.14M | View on EDGAR | |
| Brennan Katherine | Officer | 1,197 | $225K | View on EDGAR | |
| Jones John Jude | Officer | 6,500 | $1.25M | View on EDGAR |
Stock trades in MRSH disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale | $50,001 to $100,000 | Joint | 20 days | Original filing | |||
| Sale (partial) | $50,001 to $100,000 | Joint | 26 days | Original filing | |||
| Sale (partial) | $100,001 to $250,000 | Joint | 16 days | Original filing | |||
| Sale (partial) | $1,001 to $15,000 | Joint | 11 days | Original filing | |||
| Sale (partial) | $1,001 to $15,000 | Joint | 23 days | Original filing |
House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of MRSH beside its insider purchases is in the Congress Tracker.
MRSH insider trading FAQ
What is the latest insider trade for MRSH?
MARSH & MCLENNAN COMPANIES, INC. (MRSH) had 15 insider filings in the last 90 days, with the most recent on 2026-09-03. The full record for MRSH runs to 120 Form 4 filings, the earliest from 2024-10-31. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MRSH stock?
No insider purchases of MRSH were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling MRSH stock?
6 insider sales of MRSH were filed in the last 90 days, totaling $8.21M.
Where can I see MRSH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MRSH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Financials companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Katherine Brennan view on EDGAR
- - John Q. Doyle view on EDGAR
- - Morton O. Schapiro view on EDGAR
- - Anthony Anderson view on EDGAR
- - Deborah C. Hopkins view on EDGAR
- - Tamara Ingram view on EDGAR
- - Lloyd M. Yates view on EDGAR
- - Jane H. Lute view on EDGAR
- - Jan Siegmund view on EDGAR
- - Steven A. Mills view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Financials
- Where MRSH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MRSH with a 7-day demo
- MRSH on your watchlist
- Every MRSH Form 4 filing on record
- Up to 3 months of MRSH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive